This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Millennium Pharmaceuticals Limited, Wyeth. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2006 - 2009)
- Sugar land, TX (US) (2010)
Company Filing History:
Years Active: 2006-2010
Title: Ming Diana Qian: Innovator in Monoclonal Antibodies and Glycoprotein Research
Introduction
Ming Diana Qian is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and glycoprotein research. With a total of 4 patents to his name, Qian's work has the potential to impact therapeutic and diagnostic applications.
Latest Patents
One of his latest patents is titled "Anti-TrkB monoclonal antibodies and uses thereof." This invention provides monoclonal antibodies for human TrkB, which can bind and activate this receptor. The antibodies are selective for human TrkB, ensuring they do not bind or activate human TrkA or human TrkC. Additionally, the invention includes humanized versions of these antibodies and pharmaceutical compositions that utilize them for treatment, detection, or purification purposes.
Another significant patent is "Glycoprotein VI and uses thereof." This invention encompasses isolated nucleic acid and polypeptide molecules that encode glycoprotein VI, a crucial component in platelet-collagen interactions. The patent also covers antisense nucleic acid molecules, expression vectors, and non-human transgenic animals that incorporate the nucleic acid molecules. Furthermore, it provides methods for diagnostic, screening, and therapeutic applications utilizing these compositions.
Career Highlights
Ming Diana Qian has worked with notable companies in the biotechnology sector, including Millennium Pharmaceuticals Limited and Wyeth. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field.
Collaborations
Throughout his career, Qian has collaborated with esteemed colleagues such as Davinder Gill and Seongeun Cho. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Ming Diana Qian is a distinguished inventor whose work in monoclonal antibodies and glycoprotein research has the potential to advance medical science. His contributions are significant in the realm of biotechnology, and his patents reflect a commitment to innovation and improvement in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile